Balyasny Asset Management’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Balyasny Asset Management’s Portfolio XAGE Stock Details XAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-49,500	Closed	-$15.1M	–	2896
2023 Q1	$15.1M	Hold	49,500	–	–	0.04%	624
2022 Q4	$14.7M	Hold	49,500	–	–	0.04%	599
2022 Q3	$14.5M	Hold	49,500	–	–	0.04%	539
2022 Q2	$14.4M	Hold	49,500	–	–	0.05%	528
2022 Q1	$14.5M	Hold	49,500	–	–	0.05%	557
2021 Q4	$14.4M	Hold	49,500	–	–	0.05%	531
2021 Q3	$14.4M	Buy	+49,500	New	+$14.4M	0.06%	436

Other funds holding XAGE

PSAMP

P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

PMAM

Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return

Balyasny Asset Management's XAGE Position: Q2 2023 in Review

Balyasny Asset Management sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q2 2023, closing a stake of 49,500 shares — an estimated $15.1M sold.

Balyasny Asset Management first reported a position in XAGE in Q3 2021 and held it in 7 quarters. The position peaked at $15.1M in Q1 2023. 35 funds tracked by Wall St. Rank hold XAGE as of Q2 2023.

Balyasny Asset Management reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Balyasny Asset Management sold 49,500 Longevity Health Holdings, Inc. Common Stock shares in Q2 2023, an estimated $15.1M.
Balyasny Asset Management first reported a position in Longevity Health Holdings, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
Balyasny Asset Management's Longevity Health Holdings, Inc. Common Stock position peaked at $15.1M in Q1 2023.
35 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q2 2023.

Based on Balyasny Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.